ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism

Abstract Background Kidney cancer is a common adult malignancy in the USA. Clear cell renal cell carcinoma (ccRCC), the predominant subtype of kidney cancer, is characterized by widespread metabolic changes. Urea metabolism is one such altered pathway in ccRCC. The aim of this study was to elucidate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sanika Khare, Laura C. Kim, Graham Lobel, Paschalis-Thomas Doulias, Harry Ischiropoulos, Itzhak Nissim, Brian Keith, M. Celeste Simon
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/c58358261d474004af1c1f7c4c61d199
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c58358261d474004af1c1f7c4c61d199
record_format dspace
spelling oai:doaj.org-article:c58358261d474004af1c1f7c4c61d1992021-12-05T12:23:14ZASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism10.1186/s40170-021-00271-82049-3002https://doaj.org/article/c58358261d474004af1c1f7c4c61d1992021-12-01T00:00:00Zhttps://doi.org/10.1186/s40170-021-00271-8https://doaj.org/toc/2049-3002Abstract Background Kidney cancer is a common adult malignancy in the USA. Clear cell renal cell carcinoma (ccRCC), the predominant subtype of kidney cancer, is characterized by widespread metabolic changes. Urea metabolism is one such altered pathway in ccRCC. The aim of this study was to elucidate the contributions of urea cycle enzymes, argininosuccinate synthase 1 (ASS1), and argininosuccinate lyase (ASL) towards ccRCC progression. Methods We employed a combination of computational, genetic, and metabolomic tools along with in vivo animal models to establish a tumor-suppressive role for ASS1 and ASL in ccRCC. Results We show that the mRNA and protein expression of urea cycle enzymes ASS1 and ASL are reduced in ccRCC tumors when compared to the normal kidney. Furthermore, the loss of ASL in HK-2 cells (immortalized renal epithelial cells) promotes growth in 2D and 3D growth assays, while combined re-expression of ASS1 and ASL in ccRCC cell lines suppresses growth in 2D, 3D, and in vivo xenograft models. We establish that this suppression is dependent on their enzymatic activity. Finally, we demonstrate that conservation of cellular aspartate, regulation of nitric oxide synthesis, and pyrimidine production play pivotal roles in ASS1+ASL-mediated growth suppression in ccRCC. Conclusions ccRCC tumors downregulate the components of the urea cycle including the enzymes argininosuccinate synthase 1 (ASS1) and argininosuccinate lyase (ASL). These cytosolic enzymes lie at a critical metabolic hub in the cell and are involved in aspartate catabolism and arginine and nitric oxide biosynthesis. Loss of ASS1 and ASL helps cells redirect aspartate towards pyrimidine synthesis and support enhanced proliferation. Additionally, reduced levels of ASS1 and ASL might help regulate nitric oxide (NO) generation and mitigate its cytotoxic effects. Overall, our work adds to the understanding of urea cycle enzymes in a context-independent of ureagenesis, their role in ccRCC progression, and uncovers novel potential metabolic vulnerabilities in ccRCC.Sanika KhareLaura C. KimGraham LobelPaschalis-Thomas DouliasHarry IschiropoulosItzhak NissimBrian KeithM. Celeste SimonBMCarticleccRCCUrea cycleArgininosuccinate synthase 1Argininosuccinate lyaseAspartateDNA synthesisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancer & Metabolism, Vol 9, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic ccRCC
Urea cycle
Argininosuccinate synthase 1
Argininosuccinate lyase
Aspartate
DNA synthesis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle ccRCC
Urea cycle
Argininosuccinate synthase 1
Argininosuccinate lyase
Aspartate
DNA synthesis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Sanika Khare
Laura C. Kim
Graham Lobel
Paschalis-Thomas Doulias
Harry Ischiropoulos
Itzhak Nissim
Brian Keith
M. Celeste Simon
ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism
description Abstract Background Kidney cancer is a common adult malignancy in the USA. Clear cell renal cell carcinoma (ccRCC), the predominant subtype of kidney cancer, is characterized by widespread metabolic changes. Urea metabolism is one such altered pathway in ccRCC. The aim of this study was to elucidate the contributions of urea cycle enzymes, argininosuccinate synthase 1 (ASS1), and argininosuccinate lyase (ASL) towards ccRCC progression. Methods We employed a combination of computational, genetic, and metabolomic tools along with in vivo animal models to establish a tumor-suppressive role for ASS1 and ASL in ccRCC. Results We show that the mRNA and protein expression of urea cycle enzymes ASS1 and ASL are reduced in ccRCC tumors when compared to the normal kidney. Furthermore, the loss of ASL in HK-2 cells (immortalized renal epithelial cells) promotes growth in 2D and 3D growth assays, while combined re-expression of ASS1 and ASL in ccRCC cell lines suppresses growth in 2D, 3D, and in vivo xenograft models. We establish that this suppression is dependent on their enzymatic activity. Finally, we demonstrate that conservation of cellular aspartate, regulation of nitric oxide synthesis, and pyrimidine production play pivotal roles in ASS1+ASL-mediated growth suppression in ccRCC. Conclusions ccRCC tumors downregulate the components of the urea cycle including the enzymes argininosuccinate synthase 1 (ASS1) and argininosuccinate lyase (ASL). These cytosolic enzymes lie at a critical metabolic hub in the cell and are involved in aspartate catabolism and arginine and nitric oxide biosynthesis. Loss of ASS1 and ASL helps cells redirect aspartate towards pyrimidine synthesis and support enhanced proliferation. Additionally, reduced levels of ASS1 and ASL might help regulate nitric oxide (NO) generation and mitigate its cytotoxic effects. Overall, our work adds to the understanding of urea cycle enzymes in a context-independent of ureagenesis, their role in ccRCC progression, and uncovers novel potential metabolic vulnerabilities in ccRCC.
format article
author Sanika Khare
Laura C. Kim
Graham Lobel
Paschalis-Thomas Doulias
Harry Ischiropoulos
Itzhak Nissim
Brian Keith
M. Celeste Simon
author_facet Sanika Khare
Laura C. Kim
Graham Lobel
Paschalis-Thomas Doulias
Harry Ischiropoulos
Itzhak Nissim
Brian Keith
M. Celeste Simon
author_sort Sanika Khare
title ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism
title_short ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism
title_full ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism
title_fullStr ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism
title_full_unstemmed ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism
title_sort ass1 and asl suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism
publisher BMC
publishDate 2021
url https://doaj.org/article/c58358261d474004af1c1f7c4c61d199
work_keys_str_mv AT sanikakhare ass1andaslsuppressgrowthinclearcellrenalcellcarcinomaviaalterednitrogenmetabolism
AT laurackim ass1andaslsuppressgrowthinclearcellrenalcellcarcinomaviaalterednitrogenmetabolism
AT grahamlobel ass1andaslsuppressgrowthinclearcellrenalcellcarcinomaviaalterednitrogenmetabolism
AT paschalisthomasdoulias ass1andaslsuppressgrowthinclearcellrenalcellcarcinomaviaalterednitrogenmetabolism
AT harryischiropoulos ass1andaslsuppressgrowthinclearcellrenalcellcarcinomaviaalterednitrogenmetabolism
AT itzhaknissim ass1andaslsuppressgrowthinclearcellrenalcellcarcinomaviaalterednitrogenmetabolism
AT briankeith ass1andaslsuppressgrowthinclearcellrenalcellcarcinomaviaalterednitrogenmetabolism
AT mcelestesimon ass1andaslsuppressgrowthinclearcellrenalcellcarcinomaviaalterednitrogenmetabolism
_version_ 1718371984424828928